In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as “a New Antitumor Agent” Candidate by Ligand-Targeted Superantigens Technique
AUTHORS
Abbas Ali Imani-Fooladi 1 , Forough Yousefi 2 , Seyed Fazloallah Mousavi 2 , Jafar Amani 1 , *
How to Cite: Imani-Fooladi A A, Yousefi F, Mousavi S F, Amani J . In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as “a New Antitumor Agent” Candidate by Ligand-Targeted Superantigens Technique, Int J Cancer Manag. 2014 ; 7(3):e80546.
ARTICLE INFORMATION
International Journal of Cancer Management:
7 (3); e80546
Published Online:
September
30,
2014
Article Type:
Research Article
Received:
April
22,
2014
Accepted:
June
25,
2014
READ FULL TEXT
COMMENTS
LEAVE A COMMENT HERE: